ENZ Insider Trading Activity and SEC Form 4 Filings
ENZ insider trading summary
No open-market insider purchases or sales of Enzo Biochem Inc (ENZ) have been reported on SEC Form 4 in the past 12 months.
Latest ENZ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 13, 2023 | James G. Wolf | Insider | Buy | $6K (5,000 @ $1.28) |
| Feb 13, 2023 | James G. Wolf | Insider | Buy | $6K (5,000 @ $1.29) |
| Feb 10, 2023 | James G. Wolf | Insider | Buy | $6K (5,000 @ $1.29) |
| Jan 27, 2023 | James G. Wolf | 10% Owner | Buy | $17K (11,800 @ $1.40) |
| Nov 23, 2022 | Hamid Erfanian | Chief Executive Officer | Buy | $197K (100,000 @ $1.97) |
| Nov 1, 2022 | James G. Wolf | 10% Owner | Buy | $8K (3,500 @ $2.15) |
| Nov 1, 2022 | James G. Wolf | 10% Owner | Buy | $11K (5,000 @ $2.14) |
| Oct 31, 2022 | James G. Wolf | 10% Owner | Buy | $31K (14,500 @ $2.15) |
| Jul 15, 2022 | Kara Cannon | Chief Operating Officer | Buy | $6K (2,500 @ $2.42) |
| Jul 12, 2022 | Bradley Louis Radoff | Director | Buy | $28K (12,500 @ $2.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.